Re-Vana Therapeutics Revenue and Competitors
Employee Data
- Re-Vana Therapeutics has 20 Employees.
- Re-Vana Therapeutics grew their employee count by 43% last year.
Re-Vana Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 20 | 43% | N/A | N/A |
What Is Re-Vana Therapeutics?
Re-Vana is developing photocrosslinked technologies for delivery of a wide range of therapeutics that may dramatically extend the time between intravitreal, topical or other injectable routes of administrations to the eye. In addition, we can reduce or potentially eliminate the need for topical drug delivery. Our technologies may lead to a new generation of drugs that will only require 1-2 intravitreal or anterior segment administrations per year. The Re-Vana platforms may also be used with many drugs that have recently become generics or biosimilars that have demonstrated outstanding efficacy for short durations of time.
keywords:N/A
N/A
Total Funding
20
Number of Employees
N/A
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Belfast
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.2M | 22 | 10% | N/A |
#2 | $1.8M | 22 | -8% | N/A |
#3 | $2.2M | 22 | 0% | N/A |
#4 | $1.7M | 23 | -15% | N/A |
#5 | $2.4M | 24 | 4% | N/A |